Yasuhiro Fujsawa

84PUBLICATIONS
100CO-AUTHORS
Clinical sciences not elsewhere classifiedMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (84)

|Nov 02, 2026
Clinical Characteristics, Treatment Patterns, and Survival Outcomes of Cutaneous Angiosarcoma in Japan: A 3-Year Analysis of the Japan Skin Cancer Registry Study (JSCaRS).

|Jan 08, 2026
Phase III Study Investigating the Safety and Efficacy of TM5614 in Combination With Nivolumab for the Treatment of Unresectable Malignant Melanoma: Protocol.

Taku Fujimura, Koji Yoshino, Hiroshi Kato

|Jan 07, 2026
Genomic and transcriptomic analyses of melanoma in Japanese patients reveal candidate biomarkers for immune checkpoint inhibitor responders.

T Kimura, N Tanaka, T Maekawa

|Dec 31, 2025
Real-World Efficacy of Chemotherapy in Patients With Advanced Unresectable Extramammary Paget Disease: A Retrospective Multicenter Study of 138 Japanese Patients.

Azusa Miyashita, Satoshi Fukushima, Koji Yoshino

|Nov 29, 2025
Tear Fluid Indirect Immunofluorescence for Assessing Disease Activity in Ocular Mucous Membrane Pemphigoid: First Report of a New Method for Monitoring Disease Progression.

Nobushige Kohri, Kazuki Yatsuzuka, Norito Ishii

|Oct 16, 2025
Novel Therapeutic Approaches for Cutaneous Angiosarcoma, Particularly Focusing on Immune Checkpoint Inhibitors.

Yasuhiro Fujisawa

Pageof 14

Frequent Collaborators

39 joint publications

Yoshiyuki Nakamura

37 joint publications

Naoko Okiyama

26 joint publications

Rei Watanabe

16 joint publications

Yosuke Ishitsuka